Shijia Yu

445 citations
15 papers · 345 indexed · h-index 10
Topics
Cancer-related molecular mechanisms research (6 papers)MicroRNA in disease regulation (3 papers)Neurological Disease Mechanisms and Treatments (2 papers)
Partner nations
China

In The Last Decade

Shijia Yu

14 papers receiving 339 citations

Peers

Shijia Yu
Comparison fields: 5 of 75
  • Molecular Biology 183
  • Cancer Research 143
  • Epidemiology 63
  • Pulmonary and Respiratory Medicine 37
  • Neurology 36
Replace Dongyao Hou with:
Dongyao Hou China
Yun-Hee Bae South Korea
Si Guo China
Cui Zhou China
Shuilong Leng China
Maryam Adelipour Iran
Huayan Wu China
Cecilia Pandini Italy
Xiaoyi Shi China
Chen‐Xue Mao China
Shijia Yu relative to Dongyao Hou China Dongyao Hou's profile →
Citations per field
00.5×20×40×53×
Dongyao Hou · 1×
Citations per year

Countries citing papers authored by Shijia Yu

Since Specialization
Citations

This map shows the geographic impact of Shijia Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shijia Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shijia Yu more than expected).

Fields of papers citing papers by Shijia Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shijia Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shijia Yu. The network helps show where Shijia Yu may publish in the future.

Co-authorship network of co-authors of Shijia Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shijia Yu. A scholar is included among the top collaborators of Shijia Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shijia Yu. Shijia Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 7
2 45
3 2
4 10
5 10
6 34
7 15
8 6
9 15
10 109
11 12
12 30
13 47
14
Effects of Mudan particles on serum 5-HT and β-EP expressions in diabetic rats
1
15
Effects of Rhein on resistin mRNA expression of adipose tissue and plasma free fatty acid in diabetic obese rats
2

About Shijia Yu

Shijia Yu is a scholar working on Cancer Research, Neurology and Molecular Medicine, having authored 15 papers that have together received 345 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (3 papers) and Neurological Disease Mechanisms and Treatments (2 papers). The work is most often cited by research in Cancer Research (143 citations), Molecular Medicine (26 citations) and Neurology (36 citations). Shijia Yu has collaborated with scholars based in China. Frequent co-authors include Juan Feng, Mingjun Yu, Zhongqi Bu, Xin He, Lulu Wen, Tao Bai, Pingping He, Yun Qiao, Xue Cai and Yongsheng Chen. Their work appears in journals such as Frontiers in Pharmacology, Aging Cell and Journal of Cellular and Molecular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026